America Great Health (AAGH)

[paup]

Aagh has established mature high-tech projects with solid earnings expectations, such as Cardio Spectrum Diagnostic System, the world’s 4th generation stethoscopes, proton beam device for cancer treatment, stem cell factors, skin stem cells, hair follicle stem cells, cardiac muscle stem cells, biopharmaceuticals, and dietary supplement products with significant beneficial results, etc. Since it has established its research and development, consulting, operation and management teams, Aagh has an organizational structure fully meeting the requirements of United States Securities and Exchange Commission (SEC). Aagh has signed or plans to sign merger and acquisition agreements with 6 to 8 enterprises in America and China. With considerable corporate earnings to be realized upon due diligence and acquisition, Aagh can fully satisfy performance requirements for NASDAQ main board listing. AAGH stocks which were originally scheduled to be listed on main board in 3 to 5 years are expected to be listed on NASDAQ main board in two years. An ahead of the curve opportunity as of right now. A sniff of the above drove stock to .95 within last year, when all becomes public, PPS will make investors very happy.